Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of Triapine (3-AP) and gemcitabine for metastatic non-small cell lung cancer has completed enrollment and st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Triapine (3-AP) (3-aminopyridine-2-one)

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED